| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.36 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |